RecruitingNCT04482374

Puberty Suppression and Cardiometabolic Health

Effects of Puberty and Pubertal Suppression on Insulin Sensitivity, Metabolic Rate and Vascular Health

Sponsor

University of Colorado, Denver

Enrollment

30 participants

Start Date

Aug 10, 2020

Study Type

OBSERVATIONAL

Conditions

Insulin Sensitivity/Resistance Endothelial Dysfunction Vascular Stiffness Transgenderism

Summary

This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls.

Eligibility

Sex: MALEMin Age: 9 YearsMax Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with endothelial dysfunction, insulin sensitivity/resistance, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 9 Years to 14 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.